Observe Medical ASA – Primary insider notice
Reference is made to the ongoing rights issue of 4,090,909 new shares to a subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue").
Navamedic ASA ("NAVA"), represented at the Company's board of directors by Kathrine Gamborg Andreassen, has today, on 25 June 2020, in total subscribed for 1,022,727 Offer Shares of which 853,235 Offer Shares were subscribed through the exercise of subscription rights and 169,492 Offer Shares were over-subscribed.
Subject to NAVA receiving full allocation for its subscription of Offer Shares pursuant to the allocation criteria for the Rights Issue, NAVA, with its related parties, will own 4,222,727 shares in the Company, equal to approximately 21.73% of the outstanding shares in the Company following completion of the Rights Issue.
This information is subject to disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.
Stevanato beslutar om investering i ICOcap® tillverkning
Stevanato meddelade i sin industriella plan för 2020 – 2023 att de avser investera nästan Euro 400 miljoner i tillverkning och FoU program för drug delivery system. En del av denna investering avser tillverkning av ICOcap®. Denna uppdatering följer på pressmeddelandet från 27 maj att ICOcap® hade er...
Stevanato to invest in ICOcap® manufacturing
Stevanato announced in their industrial plan for 2020 – 2023 that they intend to invest almost Euro 400 million in manufacturing and R&D programs for drug delivery systems. A share of this investment will be allocated to the manufacturing of ICOcap®. This update follows the announcement May 27 t...
Mentice Appoints Thanos Karras as Americas General Manager to Accelerate Group’s Growth Strategy
Gothenburg, Sweden Mentice AB (STO: MNTC) today announced the appointment of Thanos Karras as the company’s new General Manager for Americas. Thanos’ appointment will play a critical role in supporting Mentice’s continual growth strategy and will help accelerate its leadership position in high fidel...
Observe Medical ASA – Last day of trading in subscription rights
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE AP...